Cytokinetics Overview
Cytokinetics Target Price
Analysts' 12-month price predictions for CYTK.
Share Price
$59.53
Average Target Price
$103.67
74.1% upside
74.1% upside3 analysts in the last 4 months
High: $106 | Low: $99
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-09 | OppenheimerJustin Kim | $106 | 78.1% upside |  |
| 2024-05-09 | JMP SecuritiesJason Butler | $106 | 78.1% upside | |
| 2024-04-05 | Mizuho SecuritiesSalim Syed | $99 | 66.3% upside | |
| 2022-12-23 | Needham | $58 |  2.6% downside | |
| 2022-12-20 | Truist Financial | $60 | 0.8% upside | |
| 2022-08-23 | Raymond JamesDane Leone | $63 | 5.8% upside | |
| 2022-06-09 | Piper SandlerYasmeen Rahimi | $72 | 20.9% upside | |
| 2022-04-30 | H.C. WainwrightJoseph Pantginis | $75 | 26% upside | |
| 2021-12-20 | BarclaysCarter Gould | $52 | 12.6% downside | |
| 2021-11-18 | Raymond JamesDane Leone | $54 | 9.3% downside | |
| 2021-10-08 | Morgan StanleyJeffrey Hung | $45 | 24.4% downside | |